What would you do in my situation? I've just completed 6 rounds of chemotherapy for stage 3 serous papillary adenocarcinoma, high grade. I've been asked to take part in a phase 2 (vaccine) study for abagovomab.
Abagovomab is a mouse protein that resembles CA-125. The HOPE is that if they inject this protein, my body will start to build antibodies for the protein, and once the antibodies are present, they will be able to attack any ovarian cancer cells that appear. At this point, it's not proven, but the study aims to prove that it works.
My concerns:
1. If I join this study, my CA-125 can not be used to monitor for recurrence. I would have to rely on CT scans only. I know CA-125 is not perfect, and neither is CT scans, and I'm concerned about that.
2. It's a 2:1 ratio (which means that I have 1/3 chance of receiving placebo) and won't know that I have placebo (and CA-125 will not be able to be used anyway even though in this case it would be accurate - hope that makes sense).
3. It's only in Phase 2. I work at a pharmaceutical company and I know how very MANY phase 2 drugs wind up doing absolutely nothing.
4. If a better drug / vaccine comes up that happens to utilize mouse protein, I will NOT be able to enroll in a clinical trial for that drug. I know new and improved drugs come up all the time.
My oncologist is concerned about the high grade of my cancer, and said she would still take the chance and go on the study. Her reasoning being that we want to do anything we can to prevent a recurrence in the first place.
A friend of mine who has worked in oncology (at a pharma company) for a long time said in his opinion (based on the vaccine being only phase 2, etc. my reasonings 1-3 above) he would not take it. He was also concerned that since there are only 2 ways to monitor, CT-scan CA-125, and neither is perfect, taking one away could cause the drs. to miss any possible recurrences while they are small.
What are your thoughts?





Add to the discussion